
NexLife Review
Best for: pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1
NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo). Works exclusively with LegitScript-certified, NABP-accredited pharmacies.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
NexLife is a solid telehealth option with balanced features and pricing.
NexLife at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $145/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Coaching
- FDA status
- No FDA warning letter on record
How we scored NexLife
Each dimension is scored algorithmically from NexLife’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.8/10At $145/mo, NexLife runs about 15% below the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.4/10NexLife offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.4/10Online intake and platform experience — consult included in the price; 5 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).
Accessibility10%
5.4/10NexLife's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.5/10Coaching/dietitian access included.
How we verified this NexLife review
Last checked 2026-06-06- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications NexLife offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Plan ladder: $165 monthly, $149/mo 3-mo, $147/mo 6-mo, $145/mo 12-mo. $145 is the 12-month-plan rate, not a promo.
Plan ladder: $215 monthly, $195/mo 3-mo, $190/mo 6-mo, $186/mo 12-mo. $186 is the 12-month-plan rate, not a promo.
Ready to get started?
Plans and promotions change often — check NexLife's current pricing and active discounts before you decide.
What we like
- LegitScript certified platform
- Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
- Both semaglutide and tirzepatide at competitive pricing
- Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset
Watch-outs
- State availability not publicly disclosed
- Compounded only — no brand-name options
- Also covers hormone optimization and longevity
- Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
NexLife: the pharmacy-credential play in compounded GLP-1
Most compounded GLP-1 sellers ask you to trust them on faith. NexLife's whole pitch is the opposite: it leads with its pharmacy paperwork. The platform is LegitScript-certified and says it fills exclusively through LegitScript-certified, NABP-accredited pharmacies — the single strongest pharmacy-trust signal in our dataset. If the thing keeping you up at night about cheap compounded semaglutide is *where is this actually being made*, NexLife is built to answer that question. If you want brand-name Wegovy or Zepbound, this isn't your provider — it's compounded only.
What the flat pricing really means here
NexLife uses true flat pricing: the same monthly cost at every dose, with no step-ups as you titrate higher. That matters because a lot of competitors quote a low starter price and then quietly raise it as your dose climbs. Here the number you sign up at is the number you keep. The headline rate of $145 per month for compounded semaglutide is among the lowest we track — but read the fine print: that figure is the 12-month-plan rate, not a teaser.
The plans work as a ladder. Pay month-to-month and you'll pay the most; the price steps down on the 3-month, 6-month, and 12-month plans, with the floor reached only on the annual commitment. For tirzepatide it's the same structure — a higher month-to-month rate sliding down to its lowest level on the 12-month plan. There's no separate promo or first-month gimmick; the discount comes purely from committing longer.
What's bundled into the price
NexLife sells this as all-inclusive, and the bundle is genuinely fuller than most. Each plan folds in:
- The compounded medication itself — no separate per-vial charge
- Provider consultations (no add-on visit fee)
- Free expedited shipping, quoted at 1–2 day delivery
- A personalized nutrition plan
- A 1:1 fitness coaching call
That coaching-and-nutrition layer is a real extra. Plenty of low-cost compounders ship you a vial and wish you luck; NexLife at least gestures at the behavior-change side that actually drives weight loss. Just set expectations: a single fitness call and a nutrition plan are a nudge, not ongoing clinical coaching.
The medications and how they're dispensed
You get two molecules: compounded semaglutide (the active ingredient in Ozempic and Wegovy) and compounded tirzepatide (the one in Mounjaro and Zepbound). Both are dispensed through the certified pharmacy network NexLife partners with, and the platform's marketing leans hard on that accreditation chain. There are no oral or brand-name versions on offer — if you specifically need an FDA-approved branded pen, you'll pay a high three-figure list price elsewhere and should look at a brand-capable provider instead.
What actually sets NexLife apart
Strip away the marketing and the real differentiator is the credential stack. Lots of providers say 'US-based pharmacy'; NexLife names specific, checkable accreditations — LegitScript on the platform and NABP on the dispensing pharmacies — as the centerpiece of the offer rather than the footnote. For a category where the biggest risk is an unvetted source, that's a meaningful, verifiable hook, and it's why this provider scores well on pharmacy trust in our scoring methodology.
Who should pick it — and who should skip it
Choose NexLife if you're a price-conscious patient who's nervous about compounding quality, you're comfortable committing to a longer plan to hit the lowest rate, and you want medication plus light coaching in one bundled price. It's a strong fit for someone who'd otherwise pay over a thousand dollars a month for brand-name GLP-1 and wants a credentialed budget alternative.
Skip it if you want a true month-to-month deal with no strings — the cheapest advertised numbers ($145 for sema and the matching tirzepatide rate) only kick in on the 12-month plan, and the month-to-month price is noticeably higher. Also skip it if you need to confirm coverage in your state before signing up: NexLife does not publicly disclose which states it serves, so you'll have to verify availability directly. And if you want brand-name medication, this provider can't help.
Trust, safety, and the gaps
On oversight, NexLife checks out reasonably well: no FDA warning letters are on file for it in our records, and the accreditation story is its strongest card. The honest caveats are transparency gaps rather than red flags — the undisclosed state list, the fact that the lowest rates are annual-plan rates dressed up as 'from' pricing, and the spread of the brand's focus across hormone optimization, metabolic health, and longevity rather than GLP-1 alone. None of those are disqualifying, but they're worth knowing before you commit.
Bottom line
NexLife is a credible, credential-forward way to get compounded semaglutide or tirzepatide at a price that sits below the category median of $170. The accreditation emphasis is its genuine edge, and the bundled consult, shipping, nutrition plan, and coaching call add real value. The catches are equally real: the lowest rates require a year-long commitment, month-to-month costs more, brand-name isn't an option, and you'll need to confirm your state yourself. For a long-haul, budget-minded patient who cares about pharmacy provenance, it's an easy provider to recommend a closer look at.
Worth pricing against Oak ($130/month) and Yucca Health ($146/month) before you commit — both sit close to NexLife on cost and formulation.
Ready to start with NexLife?
Starting at $145/month. See current pricing and start your free consultation.
NexLife might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to NexLife
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this NexLife review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with NexLife?
Starting at $145/month. See current pricing and start your free consultation.